Targeting CD52 provides durable depletion of circulating CAR T cells in a patient with BCMA-CAR T-cell–associated parkinsonism

Blood Immunology & Cellular Therapy · Elsevier

Аннотация

Publication date: September 2026 Source: Blood Immunology & Cellular Therapy, Volume 2, Issue 3 Author(s): Lea Miebach, Adrian Schwarzer, Uwe Grunwald, Aiham Alkhayer, Matthias Grothe, Thomas Neumann, William Krüger, Jan Krönke

Читать у издателя →

Похожие статьи